✦ LIBER ✦

P-497 ZD6474 in combination with carboplatin and paclitaxel as first-line treatment in patients with NSCLC: Results of the run-in phase of a two-part randomized Phase II study

✍ Scribed by Hevmach, J.; West, H.; Kerr, R.; Prager, D.; Sandler, A.; Herbst, R.; Stewart, D.; Dimery, I.; Johnson, B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized phase II study of paclitaxe

✍ F.Y.F.L De Vos; A.M.E. Bos; M. Schaapveld; C.A.M. de Swart; H. de Graaf; A.G.J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Paclitaxel (P) in combination with carbo

✍ Zarogoulidis, K; Kontakiotis, T; Hatziapostolou, P; Tsianga, E; Papakosta, P; Go 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

A phase II study of carboplatin and pacl

✍ Giorgio, Carmelo Giannitto; Pappalardo, Alessandro; Russo, Antonio; Giuffrida, D 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB

O-103 A comparison of the antitumour eff

✍ Natale, R.; Bodkin, D.; Govindan, R.; Sleckman, B.; Rizvi, N.; Capo, A.; Germonp 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 143 KB

A phase 1 study of linifanib in combinat

✍ Horinouchi, Hidehito; Yamamoto, Noboru; Nokihara, Hiroshi; Horai, Takeshi; Nishi 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 417 KB

9007 Randomized, double-blind phase II/I

✍ Belani, C.; Ramalingam, S.; Kalemkerian, G.; Mok, T.; Rosell, R.; Ahn, M.J.; Sun 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB